Archives: Agenda

• Priorities and strategies for small biotech in partnering with CROs and vendors
• Breaking down the myths
• Identifying the right partners
• Cultivating collaborative relationships
• Managing the partnership

• Overview of the value proposition and expected financial return of patient engagement practices
• Review of current adoption levels of patient engagement practices
• Assessment of the impact of patient engagement practices on performance and quality
• Discussion of opportunities to optimize patient engagement and its impact

• Developing relationships with advocacy groups and patient communities from early stages
• How does patient advocacy differ at biotechs vs large pharma?
• Integrating patient insights into your study to ensure patients remain the priority throughout your trial

MODERATOR Hollie Schmidt, Vice President, Scientific Operations, Accelerated Cure Project for MS

• Navigating the constantly evolving vendor and CRO landscape as a small to mid sized sponsor company
• Staff turnover and layoffs: handling changes in the industry in order to ensure success
• New regulations and guidance around clinical trials in the US: how will this impact you?
• An overview of technology and innovation in the clinical trial industry: what’s working and what isn’t?

• Maximize the value of existing patient involvement efforts by “translating” patient advisory board insights into participant-facing materials
• Meet growing regulatory expectations for patient involvement in participant materials development
• Implement a co-development approach with patients and advisors review
• Internal planning tips for timelines, stakeholder engagement, and IRB submission strategies
• Best practices in health literacy to ensure clarity, trust, and accessibility

• Exploring how building authentic relationships with patients and local healthcare providers create meaningful opportunities for research participation
• Sharing how consistent engagement, education, and community-first strategies foster trust and drive better outcomes in clinical trials through real-world stories and examples from local outreach events.
• Insights into how inclusive outreach expands trial access, strengthens provider partnerships, and delivers measurable impact for both patients and sponsors